ADT Inc. (ADT) on Monday reported fourth-quarter net income of $145 million. The Boca Raton, Florida-based company said it had net income of 17 ...
Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...
CHARLESTON, SC, UNITED STATES, March 5, 2026 /EINPresswire.com/ -- Transforming Security Operations, Mentorship, and ...
As healthcare organizations face increasing operational complexity—ranging from patient flow and emergency department capacity to staffing and transfer coordination—many struggle with fragmented ...
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...
PYLARIFY TruVu™ (piflufolastat F 18) injection (also known as 18F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and ...
14d
Home Automation System Market worth $80.73 billion by 2032 - Exclusive Report by MarketsandMarkets
According to MarketsandMarkets, the Home Automation System Market is projected to reach USD 80.73 billion by 2032, growing from USD 57.71 billion ...
ADT (Nasdaq: ADT) has acquired Origin Wireless, bringing the company’s AI sensing platform and related intellectual property into the ADT ecosystem in a move aimed at advancing intelligent home ...
ADT Realty expands to Colorado, becoming the company’s 26th state, with 12 more states launching soon as the national ...
If you call us at 866-714-6466-you literally will be talking to the nation's top mesothelioma or asbestos lung cancer ...
Centauri arrives at the HIMSS26 Global Health Conference (March 9--12), celebrating a major achievement: Secure Exchange Solutions' SES Notify has been named the #1 ranked vendor for ADT Notifications ...
PEACE-2 finds adding cabazitaxel to ADT plus radiotherapy fails to improve survival in high-risk localized prostate cancer, while increasing severe toxicities and deaths.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results